![]() |
|
|
Vol. 26, Issue 5, 396-400, May 1998
Departments of
Anatomy, The distribution of pulmonary cytochrome P450 (P450 or CYP)
isoforms has been investigated primarily in immunohistochemical studies, which are neither quantitative nor reflective of the functions
of these enzymes. Studies of enzyme activities have been performed
using whole-lung homogenates or isolated cells, but there is little
information on the regioselective expression of P450 monooxygenases.
The aims of this study were to compare the activities of P450
monooxygenases in different lung subcompartments in two commonly
studied animal models, i.e. rats and monkeys, and to
explore the possibility that inducing agents would result in activity
up-regulation that is highly site-selective, using rats as a model.
Microdissection techniques were used to separate the airways from blood
vessels and lung parenchyma. In rats, CYP1A1 (ethoxyresorufin) and
CYP2B (pentoxyresorufin) dealkylase activities were highest in the
parenchyma, whereas CYP2E1 (p-nitrophenol) hydroxylase
activity was highest in the airways. P450 reductase activities were
similar in airways and parenchyma and were lower in trachea. In
monkeys, no significant site-selective differences in CYP1A1 and CYP2B1
activities were found. In contrast, CYP2E1 activity was higher in the
distal bronchioles and parenchyma than in the proximal airways. P450
reductase activities were similar in microsomes prepared from all
subcompartments of monkey lung. Induction of rat CYP1A1 activity by
-naphthoflavone (administered ip) was much greater in the airways
and lung parenchyma (~30-fold) than in the liver (~10-fold) or
trachea (~2.5-fold). Oral administration of phenobarbital or acetone
increased CYP2B and CYP2E1 activities in rat liver but had no
significant effect on P450 activities in subcompartments of rat lung.
These findings support the conclusion that there are regiospecific and
species-specific differences in the activities of P450 isoforms and
that the inducibility of rat pulmonary P450s is dependent on the
isoform and lung region.
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
D. M. Hyde, L. A. Miller, E. S. Schelegle, M. V. Fanucchi, L. S. Van Winkle, N. K. Tyler, M. V. Avdalovic, M. J. Evans, R. Kajekar, A. R. Buckpitt, et al. Asthma: a comparison of animal models using stereological methods Eur. Respir. Rev., December 1, 2006; 15(101): 122 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joshi and R. F. Tyndale INDUCTION AND RECOVERY TIME COURSE OF RAT BRAIN CYP2E1 AFTER NICOTINE TREATMENT Drug Metab. Dispos., April 1, 2006; 34(4): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Boland, C. Y. Lin, D. Morin, L. Miller, C. Plopper, and A. Buckpitt Site-Specific Metabolism of Naphthalene and 1-Nitronaphthalene in Dissected Airways of Rhesus Macaques J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 546 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Ghanem, D. Porter, L. A. Battelli, V. Vallyathan, M. L. Kashon, J. Y. Ma, M. W. Barger, J. Nath, V. Castranova, and A. F. Hubbs Respirable Coal Dust Particles Modify Cytochrome P4501A1 (CYP1A1) Expression in Rat Alveolar Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 171 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Shultz, D. Morin, A.-M. Chang, and A. Buckpitt Metabolic Capabilities of CYP2F2 with Various Pulmonary Toxicants and Its Relative Abundance in Mouse Lung Subcompartments J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 510 - 519. [Abstract] [Full Text] |
||||